BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16676573)

  • 1. [Complex role of the FA proteins in providing genome stability].
    Kluzek K; Zdzienicka MZ
    Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular biology of Fanconi anemia.
    Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
    Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fanconi anemia: genes and function(s) revisited].
    Papadopoulo D; Moustacchi E
    Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery.
    Thompson LH; Hinz JM; Yamada NA; Jones NJ
    Environ Mol Mutagen; 2005; 45(2-3):128-42. PubMed ID: 15668941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fanconi anemia: cellular and molecular features].
    Macé G; Briot D; Guervilly JH; Rosselli F
    Pathol Biol (Paris); 2007 Feb; 55(1):19-28. PubMed ID: 16904272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.
    Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F
    Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi anaemia and leukaemia - clinical and molecular aspects.
    Tischkowitz M; Dokal I
    Br J Haematol; 2004 Jul; 126(2):176-91. PubMed ID: 15238138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
    Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
    Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of Fanconi anaemia--an old problem, a new insight.
    Ahmad SI; Hanaoka F; Kirk SH
    Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.